Dysregulation of the urea cycle – potential targets for treatment and diagnosis in prostate cancer

Michael Ladurner, Helmut Klocker, Hannes Neuwirt, Iris E Eder · 2026

Read Dysregulation of the urea cycle – potential targets for treatment and diagnosis in prostate cancer by Michael Ladurner, Helmut Klocker, Hannes Neuwirt, Iris E Eder (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13472223.txt.

Description

Michael Ladurner, Helmut Klocker, Hannes Neuwirt, and Iris E Eder review in 2026 how prostate cancer rewires the urea cycle, the liver pathway that normally turns toxic ammonia into urea. In tumor cells, several cycle enzymes change their levels, diverting raw materials toward building blocks for growth such as polyamines and nucleotides. Those detours feed proliferation, add metabolic flexibility, and shape the immune surroundings of the tumor.

Therapies aiming at the detours include drugs that starve cells of arginine, one that blocks polyamine production, and one that blocks glutamine use, with combinations alongside hormone therapy discussed. Cycle byproducts are also weighed as blood or urine markers for early detection and for tracking patients during treatment. The authors call the rewiring a real vulnerability, provided combinations and marker validation hold up.

Catalog record

CREATORMichael Ladurner, Helmut Klocker, Hannes Neuwirt, Iris E Eder
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE52678
LICENSEhttps://creativecommons.org/licenses/by/4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/article/MED/PMC13472223

Browse the full library · About the Tower of Babel